BUY Sun Pharmaceutical Industries — Pankaj Randad, 21 Sept 2026

byPankaj RandadHorizon: Swing (≤2wk)21 Sept 2026via CNBC Awaaz.

Entry₹1,869Inferred

Target₹1,950

Stop loss₹1,835-1.82% risk

CMP₹1,846.46h ago

Active-1.21%+5.61%upside left 14d left

Follow Pankaj Randad for new calls(26% target hit, 82 closed calls)Get alerts Watch SUNPHARMA for new buy/sell callsGet alerts See 1 other Swing call on SUNPHARMA See 181 other Swing picks this week

Not investment advice; past performance doesn't guarantee future results. · Public beta — data is auto-extracted and may contain errors.

AI Assessment

Automated market context for this BUY call — facts from public sources, machine-classified. Not investment advice.

As of 22 Sept, 10:59 pm IST

3 supporting1 neutral2 opposing

Supports the BUY call (3)

1 other SEBI-registered advisor has an active swing BUY call on this stock, issued in the last 14 days

Advisor consensus · same horizon·21 Sept · yesterday

Sun Pharma to acquire Innovcare Lifesciences for ₹271.2 crore

NewsGoogle News·20 Sept · 2d ago

4 advisors have active short-term BUY calls on this stock

Advisor consensus · adjacent horizon·30 Jul · 2mo ago

Neutral / worth noting (1)

Sun Pharmaceutical Industries Ltd has been assigned international issuer credit ratings by Moody's Ratings (Baa1, Stable Outlook) and S&P Global Ratings (BBB+, Stable Outlook). These ratings are inves

BSE · Company Update·8 Sept · 2w ago

Weighs against the BUY call (2)

MACD below its signal line — bearish momentum

Technicals · macd·22 Sept · today

Sun Pharma subsidiaries settle US generic drug pricing antitrust case for confidential amount

NewsCnbc-Tv18·11 Sept · 2w ago

Factor classifications are AI-generated from exchange filings, verified news feeds and market data — they can be wrong or incomplete, and are not attributed to the issuing analyst. Verify every factor via its linked original before acting. This is not investment advice.

BUY Sun Pharmaceutical Industries Ltd. — Pankaj Randad

AI Assessment